By Albert Leung, Head of the Institute of Innovation and Research, Guangzhou Xujohn BioTech Co., Ltd, China
linkedin.com/in/albert-leung-cosmetics
Abstract
MCE was authorised in the EU, listed in ASEAN and later registered in China under different conditions. This article compares where each system places the regulatory gate and who holds the safety evidence after launch. It also considers what ingredient suppliers and brand teams should settle before fixing a launch timetable.
Keywords
new cosmetic ingredients; UV filters; NMPA; Regulation (EC) No 1223/2009; ASEAN Cosmetic Directive; regulatory strategy
Introduction
On 29 October 2026, China’s National Medical Products Administration (NMPA) registered BASF SE’s new UV filter, Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate (MCE), under registration number 国妆原注字20260001 (1). European readers may wonder why this was news. The EU authorised MCE through a regulation adopted in November 2020 (2), and ASEAN added it to its UV-filter list in November 2021 (3). The molecule did not change; the regulatory route did. For ingredient teams, the practical questions are where each market places the regulatory gate and who remains responsible for the evidence after launch.
The EU: ordinary ingredients and positive lists
Regulation (EC) No 1223/2009 does not require every new cosmetic ingredient to pass through a general approval or registration procedure. For an ordinary ingredient, such as a new emollient or botanical extract outside the regulated positive-list functions, the controls generally sit at product level: the Responsible Person must demonstrate safety in the Cosmetic Product Safety Report, keep the supporting evidence in the Product Information File and notify the finished product through the CPNP (4). That does not mean every ingredient can simply be put on the market. Preservatives, UV filters and colourants must be included in Annexes V, VI and IV, respectively, before they can be used for those functions. For a new ingredient seeking such listing, the Scientific Committee on Consumer Safety (SCCS) assesses the safety dossier before the European Commission amends the relevant Annex (4).
MCE’s file shows that positive listing is not a formality. SCCS found the first dossier inconclusive in July 2017. A second submission followed in July 2018, a positive opinion arrived in December 2019, and the amending regulation was adopted in November 2020 (2,5). Other timelines look very different: another UV filter, first submitted in 2009, was listed only in 2022 (6). The chemicals Omnibus proposal now in the legislative process would add an explicit application procedure for positive-list substances to the Regulation. Parliament adopted its position on 22 October 2026, but the proposal has not yet become law (7).
There is also a separate chemicals track. REACH registration applies from one tonne a year per manufacturer or importer (8). The Symrise judgment in 2023 confirmed that ECHA may require animal data on a cosmetic UV filter where worker protection is concerned (9).
ASEAN: regional listing, national implementation
The ASEAN Cosmetic Directive (ACD) follows the broad EU approach. Ordinary new ingredients do not go through an ASEAN-wide approval procedure, but colourants, preservatives and UV filters require positive listing. Responsibility for the safety evidence remains with the company in its Product Information File (10). MCE was added to the ASEAN UV-filter list at the 34th ASEAN Cosmetic Committee meeting in November 2021, with the same 3% maximum concentration as in the EU (3).
Regional agreement, however, does not mean a single launch date. Each Member State adopts annex changes through its own instrument and timetable. The ban on the UV filter 4-methylbenzylidene camphor, for example, applies from November 2028 in most Member States, but a year earlier in Brunei, Indonesia and Lao PDR (11). Product notification is national too, with validity ranging from one year in Singapore to five in Vietnam (12,13). A formula can therefore meet the ACD and still require a different administrative plan in each country.
China: novelty triggers an ingredient procedure
China begins with a different question: is the ingredient already in the Inventory of Existing Cosmetic Ingredients in China (IECIC)? If it is not, novelty alone means that the ingredient must be registered or filed before use. Since the Cosmetic Supervision and Administration Regulation took effect in 2021, registration has applied to five functions: preservatives, sunscreens, colourants, hair dyes, and freckle-removing or whitening agents. Other new ingredients are filed (14). The conditions of use can also differ. MCE’s technical requirements in China set a maximum concentration of 1%, compared with 3% in the EU and ASEAN listings (1,2,3).
The July 2026 reform did not change that basic dividing line, although some English-language summaries suggested otherwise. It narrowed the “higher-risk” category that determines the safety data required: from ten functions, including anti-hair-loss, anti-acne and anti-dandruff, to the same five (15,16). It also made wider provision for internationally validated non-animal methods and for existing safety and food-use history (16). Since 2025, China has encouraged applicants to submit a new-ingredient registration application together with a registration application for a special cosmetic using that ingredient (17).
Filing has become routine; registration remains unusual. Annual filings rose from 42 in 2022 to 169 in 2025, with a further 151 by the end of September 2026. By comparison, there was one registration in 2024 and two in 2025 (18,19). For a registered or filed new ingredient, the three-year safety-monitoring period starts when the first cosmetic product using that ingredient obtains registration or completes filing (20). By August 2026, ten new ingredients had completed monitoring and entered IECIC List II (21). A substance absent from China’s chemical inventory also needs separate registration with the Ministry of Ecology and Environment. The revised measures of 24 October 2026 exempt finished cosmetics but not their raw materials, require formal registration for annual production or import volumes below one tonne, and require the applicant to be an enterprise or public institution legally registered in China, engaged in producing or importing the substance and capable of independently bearing legal responsibility (22).
What the three systems have in common
All three systems require positive listing for preservatives, UV filters and colourants, although the routes differ. China also includes hair dyes and whitening agents in its registration category. For project teams, the practical difference is where the regulatory gate sits and who must maintain the evidence.
| Market | Where the gate sits | Ordinary new ingredient | Preservative, UV filter, colourant | Who holds the evidence after launch |
| China | The ingredient | NMPA filing | NMPA registration (also hair dyes, whitening) | Ingredient owner: three-year monitoring, then IECIC List II |
| EU | The function | No ingredient-specific pre-market approval for ordinary ingredients; product safety report and CPNP notification | Annex listing after SCCS opinion | Responsible Person for each product |
| ASEAN | The function | No regional approval; national product notification | ACD annex listing, then national adoption | Notifying company, country by country |
Table 1. New-ingredient pathways in China, the EU and ASEAN
That distinction matters after launch as well. In the EU and ASEAN, evidence for an ordinary ingredient sits in each product file, and the company placing the product on the market remains accountable. In China, the ingredient registrant or filer submits the dossier and must report annually on the ingredient’s use and safety throughout the monitoring period (14,20).
Practical planning across the three systems
I would not fix a launch timetable before settling the regulatory questions. Start with the ingredient’s function as well as its novelty. A core safety dossier should cover identity, purity, toxicology and exposure, but it needs to be adaptable for an EU safety report, an SCCS submission or an NMPA file. China’s first product registration or filing using the ingredient is a regulatory event; supply agreements should require product companies to feed safety data back to the ingredient owner. ASEAN also needs a country-by-country budget and plan alongside the regional annex review.
In my own NPD and procurement work, I call this “feed-forward anticipating control” (FAC). Before a project starts, I identify the regulatory, technical and execution problems that are most likely to arise, then remove them or design around them before they become launch problems. For ingredient work, this means checking the evidence, supplier documentation and product claims against each target market before fixing the timetable.
The three systems start from different questions. In the EU and ASEAN, the first concern is the ingredient’s function; in China, it is whether the ingredient itself is new. Nearly six years separated MCE’s EU authorisation from its registration in China. A core dossier can travel, but the regulatory plan has to be market-specific. Early attention to those differences can prevent avoidable delays.
REFERENCES AND NOTES
- National Medical Products Administration. Cosmetic New Ingredient Registration Information (化妆品新原料注册信息), record 国妆原注字20260001: Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate, registrant BASF SE, approved 29 October 2026; and Cosmetic New Ingredient Technical Requirements. NMPA Data Search, accessed 13 November 2026. https://datasearch.nmpa.gov.cn/
- Commission Regulation (EU) 2020/1684 of 12 November 2020 amending Annex VI to Regulation (EC) No 1223/2009. https://eur-lex.europa.eu/eli/reg/2020/1684/oj/eng
- Food and Drug Administration Philippines. FDA Circular No. 2022-002: Updates and amendments of the ASEAN Cosmetic Directive as adopted during the 34th ASEAN Cosmetic Committee meeting (15–16 November 2021). https://www.fda.gov.ph/fda-circular-no-2022-002-updates-and-amendments-of-the-asean-cosmetic-directive-acd-as-adopted-during-the-34th-asean-cosmetic-committee-acc-meeting-and-its-related-meetings/
- Regulation (EC) No 1223/2009 on cosmetic products, consolidated version of 18 May 2026. https://eur-lex.europa.eu/eli/reg/2009/1223/2026-05-18/eng
- Scientific Committee on Consumer Safety. Opinion on Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate (S87), Submission II, SCCS/1605/19, 13 December 2019. https://health.ec.europa.eu/system/files/2021-08/sccs_o_227_0.pdf
- Scientific Committee on Consumer Safety. Opinion on Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (HAA299), SCCS/1634/21, 2021; Commission Regulation (EU) 2022/2195 of 10 November 2022. https://health.ec.europa.eu/system/files/2022-08/sccs_o_256.pdf
- Council of the European Union. Document ST 14645/26 on the Omnibus VI (chemicals) simplification proposal, COM(2025) 531, 30 October 2026. https://data.consilium.europa.eu/doc/document/ST-14645-2026-INIT/en/pdf
- Regulation (EC) No 1907/2006 (REACH), consolidated version. https://eur-lex.europa.eu/eli/reg/2006/1907/2025-10-23
- General Court of the European Union. Case T-655/20, Symrise v ECHA, ECLI:EU:T:2023:736, 22 November 2023. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:62020TJ0655
- ASEAN. Agreement on the ASEAN Harmonized Cosmetic Regulatory Scheme, Schedule B: ASEAN Cosmetic Directive. https://agreement.asean.org/media/download/20140119114643.pdf
- Food and Drug Administration Philippines. FDA Circular No. 2026-0001: Consolidated amendments to the ASEAN Cosmetic Directive adopted during the 40th to 42nd ACC meetings. https://www.fda.gov.ph/fda-circular-no-2026-0001-consolidated-amendments-to-the-asean-cosmetic-directive-acd-as-adopted-during-the-40th-to-42nd-asean-cosmetic-committee-acc-meeting-and-their-related-meetings/
- Health Sciences Authority, Singapore. Cosmetic product notification. https://www.hsa.gov.sg/cosmetic-products/cosmetic-product-notification/submit/
- Drug Administration of Vietnam. Consolidated text of Circulars on cosmetics management, incorporating Circular 34/2025/TT-BYT, July 2025. https://dav.gov.vn/upload_images/files/VBHN%20TT%2006%2029%2034%2009%20155%20ve%20quan%20ly%20my%20pham%2023_7_2025_signed.pdf
- State Council of China. Cosmetic Supervision and Administration Regulation (化妆品监督管理条例), Decree No. 727, effective 1 January 2021, Articles 11 and 14. https://www.nmpa.gov.cn/xxgk/fgwj/flxzhfg/20200629190501801.html
- National Medical Products Administration. Announcement No. 59 of 2026: Provisions on New Cosmetic Ingredient Registration, Filing and Dossier Management, effective 15 July 2026. https://www.nmpa.gov.cn/xxgk/ggtg/hzhpggtg/jmhzhptg/20260626114523130.html
- National Medical Products Administration. Policy interpretation of the 2026 Provisions on New Cosmetic Ingredient Registration, Filing and Dossier Management, 26 June 2026. https://www.nmpa.gov.cn/directory/web/nmpa/xxgk/zhcjd/zhcjdhzhp/20260626112058185.html
- National Medical Products Administration. Announcement No. 12 of 2025: Several Provisions on Supporting Innovation in Cosmetic Ingredients. https://www.nmpa.gov.cn/xxgk/ggtg/hzhpggtg/jmhzhptg/20250206171649139.html
- National Medical Products Administration. Statistical Annual Reports on Drug Regulation, 2022, 2023 and 2024 (new cosmetic ingredients). https://www.nmpa.gov.cn/directory/web/nmpa/images/1681866563446076174.pdf; https://www.nmpa.gov.cn/directory/web/nmpa/images/1716192390012090771.pdf; https://www.nmpa.gov.cn/directory/web/nmpa/images/1755850263549015691.pdf
- National Institutes for Food and Drug Control. 2025 Annual Cosmetic Review Report (2025年度化妆品审评报告), 29 April 2026. https://www.nifdc.org.cn/nifdc/bshff/hzhpjssp/hzpsptzgg/202604281419202019999.html; and CIRS Group. Analysis report on the filing status of new cosmetic ingredients in China, September 2026. http://www.cirs-group.com/cn/cosmetics/2026-nian-9-yue-hua-zhuang-pin-xin-yuan-liao-bei-an-zui-xin-qing-kuang-fen-xi-bao-gao
- State Administration for Market Regulation. Measures for the Administration of Cosmetic Registration and Filing (化妆品注册备案管理办法), Decree No. 35, Article 19. https://www.nmpa.gov.cn/xxgk/fgwj/bmgzh/20210305140721149.html
- CIRS Group. Fifth dynamic adjustment of the Inventory of Existing Cosmetic Ingredients in China, August 2026. http://www.cirs-group.com/cn/cosmetics/yi-shi-yong-hua-zhuang-pin-yuan-liao-mu-lu-ying-lai-di-wu-ci-dong-tai-tiao-zheng-fu-wu-ci-tiao-zheng-quan-mian-shu-li
- Ministry of Ecology and Environment of China. Measures for the Environmental Management Registration of New Chemical Substances, Decree No. 40, 24 October 2026. https://www.mee.gov.cn/xxgk2018/xxgk/xxgk02/202610/t20261027_1184708.html
About the Author
Albert Leung is Head of the Institute of Innovation and Research at Guangzhou Xujohn BioTech Co., Ltd, and Immediate Past President of the Hong Kong Society of Cosmetic Chemists (HKSCC). As a Chartered Chemist (FRSC, CChem) and Chartered Scientist (CSci), he has over 20 years of experience across R&D, regulatory affairs, NPD project management, procurement and supply chain, with a particular focus on China and the wider Asian region. He specialises in navigating complex technical and sourcing challenges during product development. Albert is a visiting lecturer at HKU SPACE and a DBA Candidate at City University of Hong Kong, researching how supplier collaboration affects new product performance.
























